{
    "2019-10-31": [
        [
            {
                "time": "2019-10-31",
                "original_text": "基金收评 | 十月收官！“喝酒吃药”行情再现，接下来该买啥基金？",
                "features": {
                    "keywords": [
                        "基金",
                        "十月收官",
                        "喝酒吃药"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-11-01",
                "original_text": "北向资金净流入超70亿创2个月新高，伊利股份最受主力欢迎",
                "features": {
                    "keywords": [
                        "北向资金",
                        "净流入",
                        "伊利股份"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "消费"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-11-02",
                "original_text": "药明康德前三季研发费用4.14亿元 同比增长四成",
                "features": {
                    "keywords": [
                        "药明康德",
                        "研发费用",
                        "同比增长"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-11-03",
                "original_text": "2019年抢鲜看：513份业绩预告揭秘A股“价值牛”",
                "features": {
                    "keywords": [
                        "业绩预告",
                        "价值牛"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-11-04",
                "original_text": "恒指收涨0.9%本月涨3.1%，手机配件、生物医药股强势上涨",
                "features": {
                    "keywords": [
                        "恒指",
                        "手机配件",
                        "生物医药"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "科技",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-11-05",
                "original_text": "业绩靓丽，市值千亿CRO龙头A股封涨停，H股大涨11%",
                "features": {
                    "keywords": [
                        "业绩",
                        "CRO",
                        "涨停"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-11-06",
                "original_text": "公募成为大赢家！“药中华为”盘中涨停 这些机构抱团股火了",
                "features": {
                    "keywords": [
                        "公募",
                        "药中华为",
                        "涨停"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-11-07",
                "original_text": "药明康德A+H股股价创新高 业绩增速超预期",
                "features": {
                    "keywords": [
                        "药明康德",
                        "A+H股",
                        "创新高",
                        "业绩增速"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-11-08",
                "original_text": "药明康德前三季营收增长超三成 业务稳健毛利率近40%",
                "features": {
                    "keywords": [
                        "药明康德",
                        "营收增长",
                        "毛利率"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-11-09",
                "original_text": "医药股领涨，三季报业绩亮眼，哪些低估值高业绩标的值得关注？",
                "features": {
                    "keywords": [
                        "医药股",
                        "三季报",
                        "低估值",
                        "高业绩"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}